Tesamorelin
FDA-approved — proven visceral fat reduction
Overview
The only FDA-approved GHRH analog, originally developed for HIV-associated lipodystrophy. The strongest evidentiary base of any GH peptide — backed by double-blind, placebo-controlled clinical trials. Most potent peptide specifically for reducing visceral abdominal fat with proven, measurable results.
Key Benefits
- ✓Proven visceral fat reduction (FDA-approved indication)
- ✓Elevated GH and IGF-1 levels
- ✓Improved body composition
- ✓Cognitive function improvements
- ✓Strongest clinical evidence of any GH peptide
Dosing Protocol
How to Use
Unlike other GH peptides, tesamorelin has double-blind placebo-controlled trial data in humans. The cardiologist-preferred GH peptide choice due to its rigorous evidence base. Requires prescription.
The Science
This compound has FDA-backed clinical evidence — review the trial data and prescribing information below.
Where to Buy
FTC-disclosed affiliateEvolve Peptides
Third-party testedFull research peptide catalog — BPC-157, TB-500, CJC-1295+Ipamorelin, Sermorelin, GHK-Cu, PT-141, AOD-9604, Epithalon, DSIP, Tesamorelin and more. Third-party tested, US-based synthesis.
STACK earns a small commission from purchases through this link — at no extra cost to you.
Track Tesamorelin with the STACK app
Set dose reminders, monitor your supply, and ask AI questions about your protocol — all in one place.
All content is for informational purposes only. Peptides are research compounds. Consult a licensed healthcare provider before starting any protocol.
STACK may earn a commission when you purchase through our links at no extra cost to you. This never influences our recommendations — we only feature vendors with verified third-party testing and established quality standards.